Professor | Lifeng Fu | Asia Growth Partners

Name	Lifeng Fu
Contact Information	fulf@im.ac.cn
Language ability	Chinese, English
Province	Beijing

Name

Lifeng Fu

Contact Information

fulf@im.ac.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	University of Chinese Academy of Sciences
Faculty	Medical School
Academic Background & Achievements	2009-09 to 2016-07 Ph.D. in Science: Institute of Microbiology, Chinese Academy of Sciences 2005-09 to 2009-07 Bachelor's in Science: China Agricultural University
Work Experience	2021-11 to Present - Institute of Microbiology, Chinese Academy of Sciences - Associate Researcher 2016-07 to 2021-11 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher 2009-09 to 2016-07 - Institute of Microbiology, Chinese Academy of Sciences - Ph.D. in Science 2005-09 to 2009-07 - China Agricultural University - Bachelor's in Science
Awards	Pathogenic Microorganisms and Immunology Key Laboratory Annual Scientific Achievement Award (2020): Special Prize, Institute

University/Lab Affiliation and Title

University of Chinese Academy of Sciences

Faculty

Medical School

Academic Background & Achievements

2009-09 to 2016-07 Ph.D. in Science: Institute of Microbiology, Chinese Academy of Sciences
2005-09 to 2009-07 Bachelor's in Science: China Agricultural University

Work Experience

2021-11 to Present - Institute of Microbiology, Chinese Academy of Sciences - Associate Researcher
2016-07 to 2021-11 - Institute of Microbiology, Chinese Academy of Sciences - Assistant Researcher
2009-09 to 2016-07 - Institute of Microbiology, Chinese Academy of Sciences - Ph.D. in Science
2005-09 to 2009-07 - China Agricultural University - Bachelor's in Science

Awards

Pathogenic Microorganisms and Immunology Key Laboratory Annual Scientific Achievement Award (2020): Special Prize, Institute

Areas of Focus	Antiviral Drugs
Publications	Systematic identification of chemical components in Fufang Shuanghua oral liquid and screening of potential active components against SARS-CoV-2 protease, 11th Author, 2023 Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs, 1st Author, 2021 Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir, 6th Author, 2021 Structure-based design of 5 '-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors, 4th Author, 2021 Multiple RNA virus matrix proteins interact with SLD5 to manipulate host cell cycle, 4th Author, 2021 Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir, 11th Author, 2021 Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease, 1st Author, 2020 Chemical modification and fluorescence labeling of Escherichia coli cell wall peptidoglycan, 5th Author, 2020 Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin, 10th Author, 2019 Influenza virus matrix protein M1 interacts with SLD5 to block host cell cycle, 8th Author, 2019 Constitutive expression of StAATP, a potato plastidic ATP/ADP transporter gene, increases starch content in transgenic Arabidopsis, 2nd Author, 2017 Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor, 5th Author, 2016 Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses, 1st Author, 2016 AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana, 4th Author, 2016 Glycosynthase with Broad Substrate Specificity - an Efficient Biocatalyst for the Construction of Oligosaccharide Library, 5th Author, 2013

Areas of Focus

Antiviral Drugs

Publications

Systematic identification of chemical components in Fufang Shuanghua oral liquid and screening of potential active components against SARS-CoV-2 protease, 11th Author, 2023
Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs, 1st Author, 2021
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir, 6th Author, 2021
Structure-based design of 5 '-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors, 4th Author, 2021
Multiple RNA virus matrix proteins interact with SLD5 to manipulate host cell cycle, 4th Author, 2021
Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir, 11th Author, 2021
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease, 1st Author, 2020
Chemical modification and fluorescence labeling of Escherichia coli cell wall peptidoglycan, 5th Author, 2020
Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin, 10th Author, 2019
Influenza virus matrix protein M1 interacts with SLD5 to block host cell cycle, 8th Author, 2019
Constitutive expression of StAATP, a potato plastidic ATP/ADP transporter gene, increases starch content in transgenic Arabidopsis, 2nd Author, 2017
Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor, 5th Author, 2016
Structure-based tetravalent zanamivir with potent inhibitory activity against drug-resistant influenza viruses, 1st Author, 2016
AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana, 4th Author, 2016
Glycosynthase with Broad Substrate Specificity - an Efficient Biocatalyst for the Construction of Oligosaccharide Library, 5th Author, 2013

Antiviral Drug Design Pharmacology Virology Sars-Cov-2 Covid-19 Protease Inhibitors Chemical Components Traditional Chinese Medicine Influenza

Haibing Zhou - Wuhan University

Peng Liu - Wuhan University

Wei Wang - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us